Drug-induced lung disease.
Since there are no diagnostic studies to confirm the presence of a drug-induced lung reaction the physician will make a correct diagnosis only if he is aware of the drugs which have been identified to cause pulmonary reactions and their specific manifestations. Failure to recognize a drug-induced lung disease can lead to significant morbidity and in some cases mortality. The major drug-induced lung diseases are reviewed, the drugs being presented in the context of their clinical use and the reactions on the basis of common pathogenetic mechanisms.
D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D001168:Arthritis / Q000188:drug therapy; D004205:Cromolyn Sodium / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000209:etiology; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced*; D008297:Male; D009582:Nitrofurantoin / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D011652:Pulmonary Circulation / Q000187:drug effects; D011653:Pulmonary Diffusing Capacity / Q000187:drug effects; D011654:Pulmonary Edema / Q000139:chemically induced; D011658:Pulmonary Fibrosis / Q000139:chemically induced; D019966:Substance-Related Disorders / Q000150:complications
D000925:Anticoagulants; D000959:Antihypertensive Agents; D000970:Antineoplastic Agents; D010672:Phenytoin; D009582:Nitrofurantoin; D004205:Cromolyn Sodium